🦊/Companies

Global Innovative Platforms

OTC: GIPL

Orlando, US · Delaware corporation

Find your way into Global Innovative Platforms

146 people in our graph share verified history with the Global Innovative Platforms team — schools, employers, funds. One of them is your warm intro.

Global Innovative Platforms develops non-invasive breath analysis devices to detect heartworm infection and other diseases in animals, using proprietary gas chromatography technology and artificial intelligence software to analyze volatile organic compound patterns in breath samples. The company is currently in algorithm development for a heartworm breath test for dogs, with plans to expand its breath and air analytics platform to monitor treatment response and identify environmental hazards across multiple animal species.

Founders & leadership

ABAndrew Brown
Andrew BrowninCEO and CFOAndrew Brown is CEO and CFO of Global Innovative Platforms, which develops non-invasive breath analysis devices for veterinary diagnostics. He previously co-founded and led Doorstep Delivery, a food delivery service that was acquired for $321 million.

Reported raises · per SEC filings

Form D private placements

$470K disclosed across 3 of 4 rounds · 2023–2026

▶$5MofferedJun 2026 · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BrownExecutive Officer, Director
Offering amount
$5M
Minimum investment
$5K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$156.5KraisedApr 2026 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BrownExecutive Officer
Offering amount
$600K
Amount sold
$156.5K
Minimum investment
$5K
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$311KraisedOct 2024 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BrownExecutive Officer, Director
Offering amount
$750K
Amount sold
$311K
Minimum investment
$5K
Proceeds to insiders
$170K
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5KraisedOct 2023 · 89 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BrownExecutive Officer, Director
Offering amount
$2.5K
Amount sold
$2.5K
Minimum investment
$1
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Global Innovative Platforms do?
Global Innovative Platforms develops non-invasive breath analysis devices to detect heartworm infection and other diseases in animals, using proprietary gas chromatography technology and artificial intelligence software to analyze volatile organic compound patterns in breath samples. The company is currently in algorithm development for a heartworm breath test for dogs, with plans to expand its breath and air analytics platform to monitor treatment response and identify environmental hazards across multiple animal species.
How much funding has Global Innovative Platforms raised?
Global Innovative Platforms has disclosed $470K raised across 3 of its 4 known rounds.
Where is Global Innovative Platforms headquartered?
Global Innovative Platforms is headquartered in Orlando, US.